Fixonerve helps in fixing and restoring mobility. Fixonerve is well tolerated and efficient in treating the pain of neuropathic origin. Fixonerve is the first-line therapeutic agent with remarkable safety and efficacy. It has reported a 73% decline in adjoining medication from the second week. Fixonerve has proven significant pain reduction (VAS) from 6.37 to 2.83.
Fixonerve
- Post author:Team NLS
- Post published:July 31, 2024
- Post category:neurology
- Post comments:0 Comments